Arenicolins: C-Glycosylated Depsides from Penicillium arenicola

J Nat Prod. 2020 Mar 27;83(3):668-674. doi: 10.1021/acs.jnatprod.9b01099. Epub 2020 Jan 30.

Abstract

During investigation of the secondary metabolism of four strains of Penicillium arenicola, two new depsides, arenicolins A (1) and B (2), were isolated and characterized. Their structures were established mainly by analysis of NMR and HRMS data and by comparison with known compounds. These depsides incorporate intriguing structural features, including dual alkyl side chains and a C-glycosyl unit, with 1 also containing an acylated 2-hydroxymethyl-4,5,6-trihydroxycyclohexenone moiety. Although the arenicolins were produced by all strains tested, arenicolin A (1) was obtained using only one of five medium compositions employed, while arenicolin B (2) was produced in all media tested. Neither compound showed antibacterial or antifungal activity, but 1 exhibited cytotoxicity toward mammalian cell lines, including colorectal carcinoma (HCT-116), neuroblastoma (IMR-32), and ductal carcinoma (BT-474), with IC50 values of 7.3, 6.0, and 9.7 μM, respectively.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Biological Products / chemistry
  • Cell Line, Tumor
  • Depsides / isolation & purification
  • Depsides / pharmacology*
  • Glycosylation
  • Humans
  • Molecular Structure
  • Penicillium / chemistry*

Substances

  • Antineoplastic Agents
  • Biological Products
  • Depsides

Supplementary concepts

  • Penicillium arenicola